ChartMill assigns a Buy % Consensus number of 60% to CBMG. The Buy consensus is the weighted average rating of the current analysts ratings.
The consensus rating for Cellular Biomedicine (CBMG) is 60 / 100 . This indicates that analysts generally have a neutral outlook on the stock.